{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T22:11:04Z","timestamp":1760825464452,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jocn.2023.12.010","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T20:32:15Z","timestamp":1702931535000},"page":"185-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Vitamin D status and the risk of neuromyelitis optica spectrum disorders: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"119","author":[{"given":"Shuangxi","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bichun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2023.12.010_b0005","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2023.12.010_b0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2023.12.010_b0015","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2023.12.010_b0020","article-title":"Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis","volume":"2015","author":"Etemadifar","year":"2015","journal-title":"Mult Scler Int"},{"key":"10.1016\/j.jocn.2023.12.010_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2023.107850","article-title":"Research progress on pathogenesis and clinical treatment of neuromyelitis optica spectrum disorders (NMOSDs)","volume":"231","author":"Shen","year":"2023","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jocn.2023.12.010_b0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1152\/physrev.00014.2015","article-title":"Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects","volume":"96","author":"Christakos","year":"2016","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jocn.2023.12.010_b0035","first-page":"697","article-title":"Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential","volume":"7","author":"Dankers","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jocn.2023.12.010_b0040","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3389\/fendo.2018.00600","article-title":"Vitamin D Deficiency and Immune Disorders in Combined Endocrine Pathology","volume":"9","author":"Komisarenko","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jocn.2023.12.010_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116744","article-title":"Vitamin D and autoimmune diseases","volume":"233","author":"Illescas-Montes","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.jocn.2023.12.010_b0050","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/03009742.2016.1151072","article-title":"Vitamin D and autoimmunity","volume":"45","author":"Rosen","year":"2016","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jocn.2023.12.010_b0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/bpa.12097","article-title":"Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications","volume":"24","author":"Uzawa","year":"2014","journal-title":"Brain Pathol"},{"key":"10.1016\/j.jocn.2023.12.010_b0060","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.2147\/OPTH.S383703","article-title":"Serum Vitamin D Levels and Status in Thai Optic Neuritis Subjects: A Case-Control Study","volume":"16","author":"Puangsricharoen","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jocn.2023.12.010_b0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jocn.2018.11.024","article-title":"Low levels of vitamin D and the relationship between vitamin D and Th2 axis-related cytokines in neuromyelitis optica spectrum disorders","volume":"61","author":"Gao","year":"2019","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2023.12.010_b0070","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s10072-015-2229-7","article-title":"Reduced serum vitamin D levels in neuromyelitis optica","volume":"36","author":"Tuzun","year":"2015","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jocn.2023.12.010_b0075","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jocn.2023.12.010_b0080","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2023.12.010_b0085","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.3390\/nu7042485","article-title":"Meta-analysis of the association between vitamin D and autoimmune thyroid disease","volume":"7","author":"Wang","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.jocn.2023.12.010_b0090","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000."},{"key":"10.1016\/j.jocn.2023.12.010_b0095","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jocn.2023.12.010_b0100","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2174\/1871527321666220707111344","article-title":"Myasthenia Gravis and Vitamin D Serum Levels: A Systematic Review and Meta-analysis","volume":"22","author":"Bonaccorso","year":"2023","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.jocn.2023.12.010_b0105","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jocn.2023.12.010_b0110","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jneuroim.2016.09.006","article-title":"Serum 25-hydroxyvitamin D(3) is associated with disease status in patients with neuromyelitis optica spectrum disorders in south China","volume":"299","author":"Shan","year":"2016","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jocn.2023.12.010_b0115","first-page":"246","article-title":"Discovery and exploration of new SNPs of vitamin D receptor gene in NMOSD patients with acute attack","volume":"26","author":"Qinhua","year":"2019","journal-title":"Chin J Neuroimmunol & Neurol"},{"key":"10.1016\/j.jocn.2023.12.010_b0120","unstructured":"Pingping C, Nairong L, Huaxing M, Meini Z. Correlation of serum 25-hydroxyvitamin D levels with fatigue and quality of life in patients with optic neuromyelitis optica spectrum disorders. Chinese journal of integrative medicine on cardio-cerebrovascular disease2021."},{"key":"10.1016\/j.jocn.2023.12.010_b0125","first-page":"681","article-title":"Relationship between serum 25-(OH)D, IL-6, CD8 and the clinical characteristics and therapeutic effect of patients with NMOSD","volume":"22","author":"Jianqing","year":"2023","journal-title":"Journal of Clinical and Experimental Medicine"},{"key":"10.1016\/j.jocn.2023.12.010_b0130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaut.2017.07.007","article-title":"Modulation of inflammatory and immune responses by vitamin D","volume":"85","author":"Colotta","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jocn.2023.12.010_b0135","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.3390\/nu7095383","article-title":"Regulation of Dendritic Cell Function by Vitamin D","volume":"7","author":"Barragan","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.jocn.2023.12.010_b0140","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ecl.2017.07.010","article-title":"Regulation of Immune Function by Vitamin D and Its Use in Diseases of Immunity","volume":"46","author":"Vanherwegen","year":"2017","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jocn.2023.12.010_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107274","article-title":"Low Levels of Vitamin D in neuromyelitis optica spectrum disorder: Association with disease disability","volume":"9","author":"Min","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jocn.2023.12.010_b0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2340\/00015555-0980","article-title":"Factors influencing vitamin D status","volume":"91","author":"Tsiaras","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jocn.2023.12.010_b0155","unstructured":"Rouzibilali Y. Study on the correlation between serum 25-hydroxyvitamin D3 and immune cells in patinets with Neuromyelitis Optica Spectrum Disorder. Master's Thesis: Xinjiang Medical University; 2021."},{"key":"10.1016\/j.jocn.2023.12.010_b0160","first-page":"17","article-title":"Alterations in circulating levels of vitamin D and the association with clinical characteristics in multiple sclerosis patients","author":"Junhui","year":"2010","journal-title":"Chin J Neuroimmunol & Neurol"},{"key":"10.1016\/j.jocn.2023.12.010_b0165","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neulet.2014.04.021","article-title":"Vitamin D status and the risk of multiple sclerosis: a systematic review and meta-analysis","volume":"570","author":"Duan","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jocn.2023.12.010_b0170","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jsbmb.2015.09.016","article-title":"Species-specific regulation of innate immunity by vitamin D signaling","volume":"164","author":"Dimitrov","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jocn.2023.12.010_b0175","first-page":"527","article-title":"Vitamin D insufficiency among African-Americans in the southeastern United States: implications for cancer disparities (United States)","volume":"19","author":"Egan","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jocn.2023.12.010_b0180","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1177\/1352458510394398","article-title":"Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis","volume":"17","author":"Mowry","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2023.12.010_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17469899.2020.1723416","article-title":"Environmental and genetic risk factors in the development of neuromyelitis optica","volume":"15","author":"Naser","year":"2020","journal-title":"Expert Review of Ophthalmology"},{"key":"10.1016\/j.jocn.2023.12.010_b0190","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/ene.12898","article-title":"Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands","volume":"23","author":"van Pelt","year":"2016","journal-title":"Eur J Neurol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586823003818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586823003818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:35:28Z","timestamp":1760823328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586823003818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":38,"alternative-id":["S0967586823003818"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2023.12.010","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D status and the risk of neuromyelitis optica spectrum disorders: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2023.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}